ATE94882T1 - Heparinbindende gehirnmitogene. - Google Patents

Heparinbindende gehirnmitogene.

Info

Publication number
ATE94882T1
ATE94882T1 AT89101187T AT89101187T ATE94882T1 AT E94882 T1 ATE94882 T1 AT E94882T1 AT 89101187 T AT89101187 T AT 89101187T AT 89101187 T AT89101187 T AT 89101187T AT E94882 T1 ATE94882 T1 AT E94882T1
Authority
AT
Austria
Prior art keywords
mitogens
heparin
brain
hbbms
promotion
Prior art date
Application number
AT89101187T
Other languages
English (en)
Inventor
Peter Bohlen
Peter Gautschi-Sova
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE94882T1 publication Critical patent/ATE94882T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Insulated Conductors (AREA)
  • Organic Insulating Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)
AT89101187T 1988-01-25 1989-01-24 Heparinbindende gehirnmitogene. ATE94882T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14783588A 1988-01-25 1988-01-25
EP89101187A EP0326075B1 (de) 1988-01-25 1989-01-24 Heparinbindende Gehirnmitogene

Publications (1)

Publication Number Publication Date
ATE94882T1 true ATE94882T1 (de) 1993-10-15

Family

ID=22523098

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89101187T ATE94882T1 (de) 1988-01-25 1989-01-24 Heparinbindende gehirnmitogene.

Country Status (9)

Country Link
EP (1) EP0326075B1 (de)
JP (1) JPH01308300A (de)
AT (1) ATE94882T1 (de)
AU (1) AU624803B2 (de)
DE (1) DE68909254T2 (de)
DK (1) DK29889A (de)
ES (1) ES2058350T3 (de)
FI (1) FI890342A (de)
NO (1) NO175594C (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801426D0 (sv) * 1988-04-15 1988-04-15 Ulf Rothman Forfarande och medel for blodbehandling
US5126323A (en) * 1989-11-16 1992-06-30 Genetics Institute, Inc. Homogeneous purified k-fgf and compositions containing the same
US6448381B1 (en) 1990-01-08 2002-09-10 Barnes-Jewish Hospital DNA encoding heparin-binding growth factor
EP0452299B1 (de) * 1990-04-12 1997-06-18 EBEWE Arzneimittel Gesellschaft mbH Verwendung einer Mischung von Peptiden and Aminosäuren für die Prophylaxis oder Behandlung von Dementia
FR2665448A1 (fr) * 1990-08-01 1992-02-07 Paris Val De Marne Universite Procede d'obtention d'un peptide ayant une activite facteur de croissance, produit obtenu et son application comme medicament.
US5210026A (en) * 1990-08-20 1993-05-11 American Cyanamid Company Human mk gene and method of expression
US6511823B1 (en) * 1990-08-20 2003-01-28 American Cyanamid Corporation Heparin binding neurotrophic factor gene sequence
EP0535336A3 (en) * 1991-09-30 1993-05-19 American Cyanamid Company Mk protein as cell growth inhibitor
EP0535337A3 (en) * 1991-09-30 1993-05-19 American Cyanamid Company Cell growth inhibiting activities of heparin binding neurite-outgrowth promoting factor
FI980032A0 (fi) * 1998-01-09 1998-01-09 Heikki Matti Eemeli Rauvala Ny anvaendning av en heparin bindande, med tillvaext foerknippad molekyl
US6364912B1 (en) * 1999-09-17 2002-04-02 Depuy Orthopeaedics, Inc. Pleiotrophin-based compositions for enhancing connective tissue repair
US7888485B2 (en) 2003-03-26 2011-02-15 Georgetown University Anti-pleiotrophin antibodies and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU597323B2 (en) * 1985-11-22 1990-05-31 Teijin Limited Angiogenic factor derived from blood vessel endothelial cells
JPS62270597A (ja) * 1986-03-07 1987-11-24 プレジデント・アンド・フエロウズ・オブ・ハ−バ−ド・カレジ ヒト種類１ヘパリン結合性成長因子
CA2005600A1 (en) * 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor

Also Published As

Publication number Publication date
NO890295D0 (no) 1989-01-24
AU624803B2 (en) 1992-06-25
EP0326075B1 (de) 1993-09-22
DK29889D0 (da) 1989-01-24
AU2873789A (en) 1989-07-27
ES2058350T3 (es) 1994-11-01
DE68909254D1 (de) 1993-10-28
FI890342A (fi) 1989-07-26
NO890295L (no) 1989-07-26
JPH01308300A (ja) 1989-12-12
DE68909254T2 (de) 1994-04-28
FI890342A0 (fi) 1989-01-24
NO175594B (no) 1994-07-25
DK29889A (da) 1989-07-26
EP0326075A2 (de) 1989-08-02
NO175594C (no) 1994-11-02
EP0326075A3 (en) 1989-10-18

Similar Documents

Publication Publication Date Title
ATE259420T1 (de) Mutanten des keratinocyten-wachstumsfaktor-2 (kgf-2 oder fibroblastenwachstumsfaktor-12,fgf-12)
JPS646300A (en) Manufacture of collagen and product thereof
DK0429570T3 (da) Osteoinducerende præparater
ATE69376T1 (de) Haarwuchsmittel.
DE68909254D1 (de) Heparinbindende Gehirnmitogene.
DK0386793T3 (da) 1alfa-hydroxyvitamin D2 epimer og derivater heraf
ES2042742T3 (es) Procedimiento para preparar furanonas antiinflamatorias.
DE69130497T2 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
RU97105008A (ru) Способ лечения диспластического сколиоза у детей
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE68903907D1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
EP0241136A3 (de) Humaner, Klasse 1 Heparin bindender, Wachstumsfaktor
IT1225483B (it) Protesi ortopedica, particolarmente per la testa del femore.
DE69018357D1 (de) Mutein von HST-1 und seine Herstellung.
DE68924545D1 (de) Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln.
EP0635010A1 (de) Neue kardioprotektive wirkstoffe.
DE58906618D1 (de) Strobilurinderivate, ihre Herstellung und Verwendung.
DE3784308D1 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
RU93037867A (ru) Способ лечения длительно незаживающих ран и трофических язв кожных покровов